Genomocs, lipidomics, free radicals and proteins in Medicine -2006 September 30-October 1, 2004

Genomocs, lipidomics, free radicals and proteins in Medicine -2006 September 30-October 1, 2004
Kiev, Ukraine
Conference topics :
Molecular determinants of Abeta peptide neurotoxicity in Alzheimer?s disease
Protein Biomarker Discovery using Mass Spectrometry
Mechanisms & Modulations of Caspase-1 Pathways in Neurodegeneration
Amyloid ?-Peptide Generation by ?- and g-Secretase
Molecular Chaperones: Modulators of Cytotoxicity of Aberrantly Folded Disease Proteins
Identification and Validation of Novel Targets for the Treatment of HD
ELECTROPHORESIS OF PEPTIDES AND PROTEINS IN ISOELECTRIC BUFFERS
STABLE ISOTOPE METABOLIC LABELING COUPLED WITH MASS SPECTROMETRY
APPLICATIONS OF MULTI-PHOTON DETECTION IMAGER TO DIFFERENTIAL DISPLAY OF DNA AND PROTEINS
2D ELECTROPHORESIS AND COMPUTER IMAGING
MASS SPECTROMETRIC PROTEIN IDENTIFICATION APPROACHES FOR PROTEOMIC ANALYSES
MASS SPECTROMETRY OF INTACT PROTEINS FROM 2D GELS
Extraction Chromatography: Principles and the Achievement of Separation and Selectivity
Determination of Radionuclides in Samples Using Extraction Chromatography
Eicosanoid Standards and Lipidomics in RAW Macrophages
Glycosphingolipids: markers for development and disease
Lipid standards of Quantitative mass spectrometry
Recent advances n the analysis of chiral lipids
Proteomics and Informatics Strategies for Biomarker Discovery in Human Plasma
Regulatory Networking in the Brain Proteome
Cellular and Molecular Mechanisms of Aggregate Suppression
Neuroprotective Therapy by the Inhibition of Apoptosis
From Functional Genomics to Systems Biology
Nonspecific Effects of Intracellular and Extracellular Environments upon Protein Aggregation and Amyloid Formation
The C. elegans Stress Integron: A Systems Approach to Cell Stress, Aging and Neurodegenerative Disease
Genomic Analyses of Mutant Huntingtin and a-Synuclein in Yeast
Proteome Analysis of Nuclear Pathology of Polyglutamine Diseases
The Molecular Basis of SCA1 - A Polyglutamine Neurodegenerative Disease
A Three-Symbol Code for Organized Proteomes
Cell-derived Abeta Oligomers and Their Role in Alzheimer's Disease